Therapeutics Company Announces Major Clinical Collaboration Agreement
Clinical Collaboration Agreement Between Adaptimmune and Galapagos for Uza-cel TCR T-cell Therapy.
Disclaimer: The following article is a detailed overview of the clinical collaboration agreement between Adaptimmune Therapeutics plc and Galapagos NV. The content herein is based on publicly available information and should not be considered as medical advice. For specific medical concerns, please consult with a healthcare profe…